Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?

Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia

(2015) Ludmyla Kandratavicius et al.   BMC NEUROSCIENCE

The Effects of Sodium Nitroprusside Treatment on Cognitive Deficits in Schizophrenia

(2015) Joao Paulo Maia-de-Oliveira et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats

(2015) Aikaterini Trevlopoulou et al.   PSYCHOPHARMACOLOGY

Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week

(2015) Joao Paulo Maia-de-Oliveira et al.   SCHIZOPHRENIA RESEARCH

Ethnic differences in microvascular function in apparently healthy South African men and women

(2014) P. R. Pienaar et al.   EXPERIMENTAL PHYSIOLOGY

Sodium Nitroprusside Treatment of Clozapine-Refractory Schizophrenia

(2014) João Paulo Maia-de-Oliveira et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The biology behind the atherothrombotic effects of cigarette smoke

(2013) Adam Csordas et al.   Nature Reviews Cardiology

Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside

(2013) Jaime E. C. Hallak et al.   JAMA Psychiatry